TY - JOUR
T1 - Coronary Endothelial Dysfunction in People Living With HIV Is Related to Body Fat Distribution
AU - Goerlich, Erin
AU - Schär, Michael
AU - Bagchi, Shashwatee
AU - Soleimani-Fard, Alborz
AU - Brown, Todd T.
AU - Sarkar, Sudipa
AU - Bonanno, Gabriele
AU - Streeb, Valerie
AU - Gerstenblith, Gary
AU - Barditch-Crovo, Patricia
AU - Weiss, Robert G.
AU - Hays, Allison G.
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - Background:People living with HIV (PLWH) on antiretroviral therapy (ART) are at increased risk of atherosclerotic disease. Abnormal adipose distribution is common in PLWH and may contribute to atherosclerosis. Because coronary artery endothelial function (CEF) is impaired in early atherosclerosis, predicts future cardiovascular events, and is reduced in PLWH, we investigated associations between body fat distribution and CEF in PLWH.Setting:Prospective cohort study.Methods:PLWH on stable ART underwent MRI to quantify CEF, measured as change in coronary cross-sectional area from rest to that during isometric handgrip exercise, an endothelial-dependent stressor. Abdominal visceral and subcutaneous fat area (axial L4 level) and liver fat fraction were quantified using MRI. Linear regression was used to determine associations between CEF and independent variables.Results:Among 84 PLWH (52 ± 11 years; 33% women), mean cross-sectional area change was 0.74 ± 11.7%, indicating impaired CEF. On univariable regression analysis, CEF was inversely related to waist circumference (R =-0.31, P = 0.014), hip circumference (R =-0.27, P = 0.037), and subcutaneous fat area (R =-0.25, P = 0.031). We did not observe significant relationships between CEF and liver fat fraction, waist/hip ratio, or visceral fat area. On multivariable regression adjusted for age, sex, and race, CEF was associated with waist circumference, hip circumference, subcutaneous fat, and liver fat fraction.Conclusion:Waist and hip circumference and subcutaneous fat area are associated with impaired CEF, an established metric of abnormal vascular health in PLWH on stable ART, and may contribute to the increased rate of heart disease in this population.
AB - Background:People living with HIV (PLWH) on antiretroviral therapy (ART) are at increased risk of atherosclerotic disease. Abnormal adipose distribution is common in PLWH and may contribute to atherosclerosis. Because coronary artery endothelial function (CEF) is impaired in early atherosclerosis, predicts future cardiovascular events, and is reduced in PLWH, we investigated associations between body fat distribution and CEF in PLWH.Setting:Prospective cohort study.Methods:PLWH on stable ART underwent MRI to quantify CEF, measured as change in coronary cross-sectional area from rest to that during isometric handgrip exercise, an endothelial-dependent stressor. Abdominal visceral and subcutaneous fat area (axial L4 level) and liver fat fraction were quantified using MRI. Linear regression was used to determine associations between CEF and independent variables.Results:Among 84 PLWH (52 ± 11 years; 33% women), mean cross-sectional area change was 0.74 ± 11.7%, indicating impaired CEF. On univariable regression analysis, CEF was inversely related to waist circumference (R =-0.31, P = 0.014), hip circumference (R =-0.27, P = 0.037), and subcutaneous fat area (R =-0.25, P = 0.031). We did not observe significant relationships between CEF and liver fat fraction, waist/hip ratio, or visceral fat area. On multivariable regression adjusted for age, sex, and race, CEF was associated with waist circumference, hip circumference, subcutaneous fat, and liver fat fraction.Conclusion:Waist and hip circumference and subcutaneous fat area are associated with impaired CEF, an established metric of abnormal vascular health in PLWH on stable ART, and may contribute to the increased rate of heart disease in this population.
KW - HIV
KW - MRI
KW - coronary artery disease
KW - coronary endothelial function
KW - obesity
UR - http://www.scopus.com/inward/record.url?scp=85132452385&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000002932
DO - 10.1097/QAI.0000000000002932
M3 - Article
C2 - 35131972
AN - SCOPUS:85132452385
SN - 1525-4135
VL - 90
SP - 201
EP - 207
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - 2
ER -